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St. Luke's International University, Tokyo 104-8560, JapanColorectal cancer (CRC) is one of the leading causes of cancer death
worldwidewith themajority of cases having no previous family history.
Themost effectiveway to reducemortality is to detect precancerous ad-
enoma in an early stage. Several screening methods are now available;
however as each modality has its limitation there is no superb strategy
so far to conquer cancer death with colorectal cancer (Winawer et al.,
1997). Fecal occult blood testing (FOBT) is the most widely employed
screening tools, but sensitivity varies from 30% to 90% and depends on
whether the specimens are rehydrated or not. The value of colonoscopy
in screening can be appreciated, but it is costly and invasive. Moreover
its effectiveness also depends on the endoscopist's skill. Computed to-
mographic colonoscopy (CTC)may anothermodality and rapidly evolv-
ing, but there are no controlled trials of screening CTC (Johnson et al.,
2008). The risk of cumulative radiation exposure is also unknown. A
special adaptation of capsule endoscopy has been developed to obtain
images of the colon using tiny video cameras embedded in the two
ends of an ingested capsule; however several studies have found a rela-
tively low sensitivity for polyp detection (Rokkas et al., 2010). Current
serum markers are not sufﬁciently sensitive or speciﬁc to be used for
screening.
The advent of 16S rRNA-based analyses has allowed investigation of
the human colonic microbiota at the level of phylotypes and bacterial
species (Shen et al., 2010). The rationale of this method applying for
the colorectal cancer screening is intriguing. In the colon, trillions of
commensal bacteria, termed the microbiota, are in close proximity to
a single layer of epithelial cells. Evidence from animal and human
studies suggests that intestinal commensal bacteria are not innocent by-
standers but rather active participants in health. They contribute to the
regulation of cell proliferation, differentiation and gene expression in
host epithelial cells (Sanapareddy et al., 2012).
Goedert et al. reported a very interesting research to address a new
way of screening colorectal neoplasm (Goedert et al., 2015). They have
created a cancer screening project in Shanghai area with combined
methods of fecal immunohistochemical test (FIT), colonoﬁber and mi-
crobiota analysis. After informed consent was provided by 95 consecu-
tive FIT positive patients, 61 patients had successful fecal microbiota
proﬁling and colonoscopy. They conﬁrmed 24 completely normal pa-
tients, 20 colorectal adenoma (CRA), 2 colorectal carcinoma and 15
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mals reﬂected relative abundance of Proteobacteria taxa (p= 0.04) and,
to a lesser extent, rare candidate division TM7 taxa (p = 0.04). Median
relative abundance of Proteobacteria taxa was 3-fold higher in CRA than
in normals (p = 0.03). They developed and applied a rank-based dis-
tancemetric to quantify and test for differences in composition (beta di-
versity). This method originated with theWilcoxon rank-sum test, with
which CRA associations were observed across most of 18 detected
phyla. They suggest that this method is feasible and effective.
Recently, many efforts have beenmade to unveil the contribution of
intestinal microbiota to gut diseases, employing culture-independent
techniques (Goedert et al., 2015; McCoy et al., 2013). In contrast to gas-
tric cancer, where just one bacteria (Helicobacter pylori) has been asso-
ciated as to the disease, no single bacterial species has been identiﬁed as
a risk factor for CRC. But current studies accumulate many interesting
data from Bench to Bedside in terms of microbiota contribution to colo-
rectal neoplasm (Dennis et al., 2013).
In general, the cancer screening test needs several important points.
It must be convenient to patients, and have good sensitivity and speci-
ﬁcity with relative low cost. In terms of cost, such new technique as
16S rRNA-based analyses is still expensive. Therefore researchers have
to take the balance between patient's welfare and national economy.
Less expensive analyses such as fecal pH or organic acids including
short chain fatty acid (SCFA) may become a candidate of screening for
colorectal cancer (Ohigashi et al., 2013). Changes of these factors affect
microbial community, and promote carcinogenesis either directly or
indirectly.
While the causes of colorectal cancer are not fully known, it is be-
coming increasingly clear that the gut microbiota provide an important
contribution (Arthur et al., 2012). To identify the composition of bacte-
rial communities in the colon is an important step in our understanding
of their role in the large bowel cancer and development of effective
prognostic, preventative or therapeutic strategies. In more diverse pop-
ulations fecal microbiota analysis might be employed to improve for co-
lorectal adenoma and ultimately reduce mortality from CRC.
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